212 related articles for article (PubMed ID: 29383155)
1. Circulating cell-free DNA content as blood based biomarker in endometrial cancer.
Cicchillitti L; Corrado G; De Angeli M; Mancini E; Baiocco E; Patrizi L; Zampa A; Merola R; Martayan A; Conti L; Piaggio G; Vizza E
Oncotarget; 2017 Dec; 8(70):115230-115243. PubMed ID: 29383155
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer.
Ronchetti L; Terrenato I; Ferretti M; Corrado G; Goeman F; Donzelli S; Mandoj C; Merola R; Zampa A; Carosi M; Blandino G; Conti L; Lobascio AM; Iacobelli M; Vizza E; Piaggio G; Gurtner A
J Exp Clin Cancer Res; 2022 Apr; 41(1):151. PubMed ID: 35449078
[TBL] [Abstract][Full Text] [Related]
3. Serum DNA integrity index as a potential molecular biomarker in endometrial cancer.
Vizza E; Corrado G; De Angeli M; Carosi M; Mancini E; Baiocco E; Chiofalo B; Patrizi L; Zampa A; Piaggio G; Cicchillitti L
J Exp Clin Cancer Res; 2018 Jan; 37(1):16. PubMed ID: 29382392
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
[TBL] [Abstract][Full Text] [Related]
5. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
6. The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.
Toledano-Fonseca M; Cano MT; Inga E; Gómez-España A; Guil-Luna S; García-Ortiz MV; Mena-Osuna R; De la Haba-Rodriguez JR; Rodríguez-Ariza A; Aranda E
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802006
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.
Hammad R; Eldosoky MAER; Fouad SH; Elgendy A; Tawfeik AM; Alboraie M; Abdelmaksoud MF
Innate Immun; 2021 Apr; 27(3):240-250. PubMed ID: 33646058
[TBL] [Abstract][Full Text] [Related]
8. Circulating Cell-Free DNA Level in Prediction of COVID-19 Severity and Mortality: Correlation of with Haematology and Serum Biochemical Parameters.
Mishra S; Dubey DB; Agarwal K; Dubey DB; Verma S; Shabbir N; Kushwaha R; Reddy DH; Singh US; Ali W
Indian J Clin Biochem; 2023 Apr; 38(2):172-181. PubMed ID: 36032561
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
10. High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.
Kujala J; Hartikainen JM; Tengström M; Sironen R; Kosma VM; Mannermaa A
Cancer Med; 2020 Aug; 9(16):5922-5931. PubMed ID: 32602248
[TBL] [Abstract][Full Text] [Related]
11. Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer.
Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklinska W; Chyczewski L; Kulikowski M
Int J Cancer; 2010 Aug; 127(3):612-21. PubMed ID: 19960433
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
Pérez-Barrios C; Nieto-Alcolado I; Torrente M; Jiménez-Sánchez C; Calvo V; Gutierrez-Sanz L; Palka M; Donoso-Navarro E; Provencio M; Romero A
Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
[TBL] [Abstract][Full Text] [Related]
13. Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer.
Chen Q; Zhang ZH; Wang S; Lang JH
Onco Targets Ther; 2019; 12():11517-11530. PubMed ID: 31920340
[TBL] [Abstract][Full Text] [Related]
14. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
[TBL] [Abstract][Full Text] [Related]
15. The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA.
Henriksen TV; Reinert T; Christensen E; Sethi H; Birkenkamp-Demtröder K; Gögenur M; Gögenur I; Zimmermann BG; ; Dyrskjøt L; Andersen CL
Mol Oncol; 2020 Aug; 14(8):1670-1679. PubMed ID: 32471011
[TBL] [Abstract][Full Text] [Related]
16. Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer.
Waki K; Yokomizo K; Kawano K; Tsuda N; Komatsu N; Yamada A
Mol Clin Oncol; 2021 Feb; 14(2):29. PubMed ID: 33414910
[TBL] [Abstract][Full Text] [Related]
17. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
18. Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma.
Nakatsuka T; Nakagawa H; Hayata Y; Wake T; Yamada T; Nishibatake Kinoshita M; Nakagomi R; Sato M; Minami T; Uchino K; Enooku K; Kudo Y; Tanaka Y; Kishikawa T; Otsuka M; Tateishi R; Koike K
J Gastroenterol; 2021 May; 56(5):456-469. PubMed ID: 33712873
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer:
Morbelli S; Alama A; Ferrarazzo G; Coco S; Genova C; Rijavec E; Bongioanni F; Biello F; Dal Bello MG; Barletta G; Massollo M; Vanni I; Piva R; Nieri A; Bauckneht M; Sambuceti G; Grossi F
J Nucl Med; 2017 Nov; 58(11):1764-1769. PubMed ID: 28450567
[TBL] [Abstract][Full Text] [Related]
20. Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study.
Mayo-de-Las-Casas C; Velasco A; Sanchez D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius S; Ruiz-Miró M; Gonzalez-Tallada X; Llordella I; Tresserra F; Rodríguez S; Aldeguer E; Roman-Canal B; Bertran-Alamillo J; García-Peláez B; Rosell R; Molina-Vila MA; Matias-Guiu X
Int J Cancer; 2020 Jul; 147(1):277-284. PubMed ID: 31953839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
